New York, June 19, 2014 — Berkery Noyes, a leading independent investment bank specializing in providing mergers & acquisitions to middle-market companies in the healthcare, information, education and technology markets, announced today that the firm represented Amirsys in its sale to Elsevier. Terms of the transaction were not disclosed.
Amirsys is a leading provider of innovative healthcare information solutions in radiology, pathology, and anatomy. Its unique combination of proprietary technology and image-intensive, evidence-based content provide online problem-solving solutions and reference books to thousands of physicians and health professionals worldwide.
Amirsys delivers medical expertise with powerful technology to provide life-saving, vital information to healthcare professionals. Amirsys content is authored by a team of over 300 leading radiologists, pathologists, and anatomists.
Tom O’Connor, Berkery Noyes Managing Director, led the transaction team on behalf of Amirsys. Berkery Noyes has been involved with many of the most notable transactions in the healthcare/life science, technology and information sectors involving both financial and strategic buyers and sellers.
Berkery Noyes acted as Amirsys’ exclusive financial advisor in its negotiations with Elsevier.
About Berkery Noyes
Berkery Noyes provides strategic mergers and acquisitions transaction advisory services to middle-market healthcare, technology and information companies in the United States and internationally. The firm has advised many notable companies including ExitCare in its sale to Elsevier, Therapeutic Research in its sale to Francisco Partners, HW Wilson in its sale to EBSCO and UpToDate in its sale to Wolters Kluwer. For more information, visit www.berkerynoyes.com.
Amirsys delivers comprehensive, expert medical knowledge with powerful technology to provide life-saving, vital information to health care professionals. Its products include STATdx, RADPrimer, ImmunoQuery, AnatomyOne and Amirsys Imaging, Pathology, and Anatomy Reference Centers.